E Garry Menzel

Affiliations

  • at Black Diamond Therapeutics Inc. (BDTX), 2025-06-12
  • at Stoke Therapeutics Inc. (STOK), 2025-06-05
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2024-07-01
  • President And Ceo at Tcr2 Therapeutics Inc. (TCRR), 2023-06-01
  • Senior Vice President, Finance at Davita Healthcare Partners Inc. (DVA), 2013-09-11
  • Coo & Executive Vp, Finance at Regulus Therapeutics Inc. (RGLS), 2012-12-14
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ADAP $0.91 47,702 $43,446.98 75,056 2023-07-10 Filing
TCRR $1.06 11,000 $11,682.00 138,871 2022-12-13 Filing
TCRR $1.10 10,613 $11,674.30 149,871 2022-12-12 Filing
TCRR $1.13 10,325 $11,677.58 160,484 2022-12-09 Filing
TCRR $1.25 9,314 $11,679.76 170,809 2022-12-08 Filing